---
title: "IDEXX Laboratories, Inc. (IDXX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/IDXX.US.md"
symbol: "IDXX.US"
name: "IDEXX Laboratories, Inc."
industry: "Health Care Equipment"
datetime: "2026-04-15T09:29:28.617Z"
locales:
  - [en](https://longbridge.com/en/quote/IDXX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/IDXX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/IDXX.US.md)
---

# IDEXX Laboratories, Inc. (IDXX.US)

## Company Overview

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.idexx.com](https://www.idexx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-15T04:30:15.000Z

**Overall: B (0.30)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 6 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 10.42% |  |
| Net Profit YoY | 19.33% |  |
| P/B Ratio | 28.90 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 46387902002.95 |  |
| Revenue | 4303702000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 66.20% | A |
| Profit Margin | 24.62% | A |
| Gross Margin | 61.80% | A |
| Revenue YoY | 10.42% | B |
| Net Profit YoY | 19.33% | B |
| Total Assets YoY | 1.74% | C |
| Net Assets YoY | 0.63% | C |
| Cash Flow Margin | 111.55% | B |
| OCF YoY | 10.42% | B |
| Turnover | 1.30 | A |
| Gearing Ratio | 52.09% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - IDEXX Laboratories, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "10.42%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "19.33%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "28.90",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "46387902002.95",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "4303702000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "66.20%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "24.62%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "61.80%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "10.42%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "19.33%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "1.74%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "0.63%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "111.55%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "10.42%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "1.30",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "52.09%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 43.78 | 33/183 | 53.49 | 50.66 | 45.79 |
| PB | 28.90 | 144/183 | 35.65 | 32.77 | 28.76 |
| PS (TTM) | 10.78 | 113/183 | 13.19 | 12.21 | 10.65 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Abbott Laboratories (ABT.US) | B | C | C | C | B | B |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | B | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | B | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-08T04:00:00.000Z

Total Analysts: **15**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 5 | 33% |
| Overweight | 4 | 27% |
| Hold | 5 | 33% |
| Underweight | 1 | 7% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 584.05 |
| Highest Target | 823.00 |
| Lowest Target | 470.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/IDXX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/IDXX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/IDXX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/IDXX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**